TRIPTORELIN

TRIPTORELIN was reported 3354 times

TRIPTORELIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD FOLLICLE STIMULATING HORMONE 2 0.5000
1 PUBERTY 13 0.2281
2 TESTICULAR GERM CELL TUMOUR 7 0.2258
3 GROWTH ACCELERATED 28 0.1296
4 METASTATIC SALIVARY GLAND CANCER 4 0.1111
5 ACCESSORY BREAST 1 0.1111
6 EPIPHYSES PREMATURE FUSION 27 0.0891
7 BLOOD CORTICOSTERONE DECREASED 1 0.0833
8 HYPERURICOSURIA 3 0.0682
9 CONGENITAL MUSCULOSKELETAL DISORDER OF LIMBS 7 0.0667
10 BIOCHEMICAL PREGNANCY 6 0.0556
11 HYPERKALIURIA 3 0.0556
12 PROGESTERONE INCREASED 6 0.0541
13 URETERIC RUPTURE 2 0.0541
14 PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME 7 0.0493
15 CHRONIC INFLAMMATORY RESPONSE SYNDROME 2 0.0488
16 HYPERFIBRINOGENAEMIA 3 0.0448
17 INJECTION SITE ABSCESS STERILE 5 0.0442
18 OVARIAN HYPERSTIMULATION SYNDROME 101 0.0433
19 BLOOD LUTEINISING HORMONE INCREASED 10 0.0407
20 BLOOD GONADOTROPHIN INCREASED 1 0.0400
21 PITUITARY APOPLEXY 7 0.0398
22 CONGENITAL MUSCULOSKELETAL DISORDER OF SPINE 2 0.0392
23 PROCTITIS HAEMORRHAGIC 3 0.0385
24 DIFFUSE PANBRONCHIOLITIS 2 0.0364
25 INTERSTITIAL LUNG ABNORMALITY 4 0.0351
26 HAEMOCONCENTRATION 6 0.0347
27 TESTICULAR SEMINOMA (PURE) 4 0.0336
28 BLOOD LUTEINISING HORMONE DECREASED 6 0.0335
29 BILATERAL BREAST BUDS 1 0.0294
30 NEUROENDOCRINE CARCINOMA OF PROSTATE 2 0.0294
31 HORMONE-DEPENDENT PROSTATE CANCER 2 0.0286
32 JOINT STABILISATION 2 0.0274
33 PUDENDAL CANAL SYNDROME 2 0.0263
34 OVARIAN ENLARGEMENT 10 0.0260
35 HYPERPHOSPHATURIA 3 0.0256
36 OVARIAN HAEMORRHAGE 6 0.0253
37 ADMINISTRATION SITE HAEMATOMA 1 0.0250
38 HYPERSENSITIVITY MYOCARDITIS 3 0.0248
39 VASCULAR MALFORMATION 5 0.0238
40 OVARIAN ATROPHY 2 0.0235
41 PRODUCT RECONSTITUTION QUALITY ISSUE 21 0.0235
42 PRECOCIOUS PUBERTY 13 0.0228
43 ANDROGENS ABNORMAL 1 0.0227
44 OPTIC NERVE COMPRESSION 3 0.0219
45 MALE REPRODUCTIVE TRACT DISORDER 2 0.0202
46 GROWTH DISORDER 5 0.0185
47 BLOOD FOLLICLE STIMULATING HORMONE DECREASED 3 0.0170
48 EPIPHYSIOLYSIS 4 0.0161
49 BREAST ENLARGEMENT 52 0.0159
50 BODY HEIGHT INCREASED 7 0.0143
51 PRODUCT DEPOSIT 22 0.0141
52 PROSTATISM 2 0.0136
53 DEFIANT BEHAVIOUR 4 0.0130
54 ABORTION LATE 1 0.0120
55 ACQUIRED HYDROCELE 1 0.0120
56 RESPIRATORY TRACT INFECTION BACTERIAL 6 0.0120
57 ADMINISTRATION SITE INFLAMMATION 1 0.0111
58 MACROSOMIA 2 0.0110
59 LIMB IMMOBILISATION 2 0.0108
60 METASTASES TO BLADDER 3 0.0105
61 HYPOURICAEMIA 3 0.0103
62 ADMINISTRATION SITE WOUND 1 0.0101
63 BLOOD GROWTH HORMONE DECREASED 2 0.0099
64 OESOPHAGEAL ATRESIA 6 0.0096
65 SECONDARY HYPOGONADISM 3 0.0091
66 BREAST ATROPHY 2 0.0090
67 ANGIOGRAM ABNORMAL 1 0.0089
68 RENAL TUBULAR DYSFUNCTION 5 0.0088
69 BODY HEIGHT ABNORMAL 1 0.0086
70 NEUROENDOCRINE CARCINOMA METASTATIC 2 0.0081
71 MENINGORRHAGIA 2 0.0080
72 NEUROSARCOIDOSIS 3 0.0080
73 RETINITIS PIGMENTOSA 2 0.0076
74 ADRENOGENITAL SYNDROME 1 0.0074
75 NORMAL PRESSURE HYDROCEPHALUS 3 0.0073
76 HYPERTRICHOSIS 13 0.0070
77 NEEDLE ISSUE 199 0.0068
78 ABSCESS STERILE 1 0.0068
79 CRYSTAL NEPHROPATHY 4 0.0068
80 BASOSQUAMOUS CARCINOMA 1 0.0067
81 NAIL TOXICITY 2 0.0067
82 TEETHING 2 0.0067
83 OESTRADIOL INCREASED 2 0.0066
84 ATTENTION-SEEKING BEHAVIOUR 1 0.0064
85 PULMONARY HYPOPLASIA 5 0.0063
86 GROWTH RETARDATION 18 0.0061
87 HYPERCALCIURIA 3 0.0061
88 HYPERCREATININAEMIA 3 0.0060
89 PHARMACEUTICAL NOMADISM 3 0.0059
90 BLOOD ALKALINE PHOSPHATASE 1 0.0054
91 SCLERODERMA RENAL CRISIS 2 0.0053
92 HAIR GROWTH ABNORMAL 36 0.0052
93 SYRINGE ISSUE 90 0.0051
94 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 2 0.0051
95 BLOOD OESTROGEN INCREASED 3 0.0051
96 BALLISMUS 1 0.0051
97 HORMONE-REFRACTORY PROSTATE CANCER 6 0.0051
98 ACIDOSIS HYPERCHLORAEMIC 3 0.0051
99 SPONTANEOUS PENILE ERECTION 3 0.0048
100 SKIN ODOUR ABNORMAL 18 0.0046
101 ECTOPIC PREGNANCY 14 0.0045
102 ALANINE AMINOTRANSFERASE 1 0.0045
103 LIQUID PRODUCT PHYSICAL ISSUE 33 0.0045
104 OVERLAP SYNDROME 3 0.0043
105 APPLICATION SITE HYPOAESTHESIA 1 0.0043
106 ASPARTATE AMINOTRANSFERASE 1 0.0041
107 HORMONE LEVEL ABNORMAL 20 0.0041
108 PRODUCT ADMINISTRATION INTERRUPTED 32 0.0041
109 AFFECT LABILITY 39 0.0040
110 OPHTHALMOPLEGIA 6 0.0038
111 HEART FAILURE WITH REDUCED EJECTION FRACTION 2 0.0037
112 ATRIAL ENLARGEMENT 1 0.0037
113 BLOOD TESTOSTERONE ABNORMAL 4 0.0036
114 ANGIOGRAM 1 0.0036
115 URTICARIA CHRONIC 2 0.0036
116 CELL DEATH 7 0.0035
117 BONE DEVELOPMENT ABNORMAL 1 0.0035
118 PRODUCT USE COMPLAINT 55 0.0035
119 BREAST SWELLING 9 0.0033
120 BLOOD TESTOSTERONE INCREASED 7 0.0033
121 CALCULUS URINARY 5 0.0032
122 PROSTATE CANCER RECURRENT 2 0.0032
123 ADNEXAL TORSION 1 0.0032
124 ANAL INFLAMMATION 2 0.0031
125 ASOCIAL BEHAVIOUR 1 0.0031
126 TUMOUR FLARE 2 0.0029
127 PROSTATIC SPECIFIC ANTIGEN INCREASED 40 0.0029
128 WAIST CIRCUMFERENCE INCREASED 3 0.0029
129 ARTERIOVENOUS FISTULA THROMBOSIS 1 0.0029
130 PRODUCT ADMINISTRATION ERROR 58 0.0029
131 RETINAL VEIN THROMBOSIS 2 0.0029
132 MOOD ALTERED 78 0.0029
133 FANCONI SYNDROME 4 0.0028
134 HYPERTENSIVE NEPHROPATHY 3 0.0028
135 LABELLED DRUG-DRUG INTERACTION ISSUE 4 0.0028
136 SYSTEMIC SCLERODERMA 2 0.0027
137 ANAESTHESIA 1 0.0027
138 PRODUCT PHYSICAL CONSISTENCY ISSUE 15 0.0027
139 PROSTATE CANCER METASTATIC 9 0.0027
140 BODY DYSMORPHIC DISORDER 1 0.0027
141 METASTASES TO LYMPH NODES 18 0.0027
142 ADENOIDECTOMY 1 0.0026
143 ASTROCYTOMA 1 0.0025
144 PITUITARY TUMOUR BENIGN 4 0.0025
145 NEUTROPENIC COLITIS 5 0.0024
146 HYDROTHORAX 2 0.0024
147 BONE FISSURE 1 0.0024
148 TWIN PREGNANCY 2 0.0024
149 AMAUROSIS 2 0.0024
150 ADNEXA UTERI PAIN 3 0.0023
151 CHOROIDAL NEOVASCULARISATION 2 0.0023
152 BELLIGERENCE 1 0.0023
153 TESTICULAR ATROPHY 2 0.0023
154 AXONAL NEUROPATHY 2 0.0023
155 FANCONI SYNDROME ACQUIRED 4 0.0023
156 RENAL COLIC 5 0.0022
157 METASTASES TO MENINGES 5 0.0022
158 VAGINAL HAEMORRHAGE 95 0.0022
159 BLOOD CHROMOGRANIN A INCREASED 1 0.0022
160 PATHOLOGICAL FRACTURE 11 0.0022
161 RESPIRATORY TRACT INFECTION VIRAL 5 0.0021
162 PELVIC VENOUS THROMBOSIS 3 0.0021
163 NORMOCYTIC ANAEMIA 3 0.0020
164 BLADDER MASS 1 0.0020
165 HYPOGONADISM 2 0.0020
166 DROWNING 2 0.0020
167 FEMORAL NECK FRACTURE 10 0.0019
168 METASTASES TO BONE 32 0.0019
169 ACUTE PROMYELOCYTIC LEUKAEMIA 2 0.0019
170 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 2 0.0019
171 FOETAL MALFORMATION 2 0.0018
172 PRODUCT PHYSICAL ISSUE 37 0.0018
173 BLOOD INSULIN INCREASED 1 0.0018
174 BLOOD GROWTH HORMONE INCREASED 1 0.0018
175 FACIAL SPASM 2 0.0018
176 TONSILLAR DISORDER 2 0.0018
177 VITH NERVE PARALYSIS 2 0.0018
178 PUSTULAR PSORIASIS 6 0.0017
179 HEART VALVE INCOMPETENCE 5 0.0017
180 ADMINISTRATION SITE PAIN 2 0.0017
181 TREATMENT DELAYED 3 0.0017
182 MOOD SWINGS 55 0.0017
183 ALLODYNIA 2 0.0017
184 TERMINAL INSOMNIA 3 0.0017
185 JUGULAR VEIN THROMBOSIS 3 0.0017
186 VENTRICULAR ARRHYTHMIA 6 0.0016
187 DYSENTERY 3 0.0016
188 INJECTION SITE ABSCESS 4 0.0016
189 HYDRONEPHROSIS 12 0.0016
190 BLOOD CREATININE DECREASED 5 0.0016
191 HYPERTRANSAMINASAEMIA 11 0.0016
192 METABOLIC DISORDER 9 0.0015
193 PRODUCT PRESCRIBING ISSUE 33 0.0015
194 OLIGOHYDRAMNIOS 5 0.0015
195 BODY MASS INDEX INCREASED 2 0.0015
196 OSTEOLYSIS 3 0.0015
197 THERAPEUTIC PROCEDURE 2 0.0014
198 VENOOCCLUSIVE LIVER DISEASE 7 0.0014
199 ALPHA 1 FOETOPROTEIN INCREASED 1 0.0014
200 BLOOD FOLATE DECREASED 1 0.0014
201 RENAL TUBULAR ACIDOSIS 3 0.0014
202 PRODUCT PREPARATION ISSUE 9 0.0014
203 DIABETIC NEPHROPATHY 3 0.0014
204 INCREASED APPETITE 26 0.0014
205 MENSTRUAL DISORDER 11 0.0013
206 ERECTILE DYSFUNCTION 34 0.0013
207 AUTOIMMUNE THYROIDITIS 5 0.0013
208 MATERNAL EXPOSURE BEFORE PREGNANCY 9 0.0013
209 BEHAVIOUR DISORDER 7 0.0013
210 OPTIC ISCHAEMIC NEUROPATHY 5 0.0013
211 ASEPTIC NECROSIS BONE 1 0.0013
212 LONG QT SYNDROME 3 0.0013
213 ABDOMINAL SYMPTOM 1 0.0012
214 HEAVY MENSTRUAL BLEEDING 11 0.0012
215 INTRAVENTRICULAR HAEMORRHAGE 3 0.0012
216 CONGESTIVE CARDIOMYOPATHY 5 0.0012
217 ABORTION SPONTANEOUS 48 0.0012
218 TONSILLECTOMY 2 0.0012
219 CEREBRAL HAEMATOMA 4 0.0012
220 PERSONALITY CHANGE 11 0.0012
221 HYPERPYREXIA 5 0.0012
222 ABSCESS DRAINAGE 1 0.0012
223 ARTERIAL STENOSIS 1 0.0011
224 KYPHOSIS 2 0.0011
225 DYSMENORRHOEA 15 0.0011
226 POLYMYOSITIS 2 0.0011
227 DISEASE PROGRESSION 133 0.0011
228 LOSS OF LIBIDO 10 0.0011
229 IMMUNE THROMBOCYTOPENIA 5 0.0011
230 SEBORRHOEA 4 0.0011
231 IMMUNE-MEDIATED MYOSITIS 3 0.0011
232 PNEUMONIA KLEBSIELLA 2 0.0011
233 INTERMENSTRUAL BLEEDING 6 0.0011
234 BONE MARROW TRANSPLANT 2 0.0011
235 HOT FLUSH 79 0.0010
236 RETINAL VEIN OCCLUSION 3 0.0010
237 HYPERTONIC BLADDER 3 0.0010
238 RHABDOMYOLYSIS 43 0.0010
239 CONVERSION DISORDER 2 0.0010
240 PURULENCE 2 0.0010
241 ASCITES 30 0.0010
242 HEPATITIS FULMINANT 3 0.0010
243 ANTISOCIAL BEHAVIOUR 1 0.0010
244 EJACULATION FAILURE 2 0.0010
245 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 17 0.0010
246 ENURESIS 4 0.0010
247 VAGINAL DISCHARGE 10 0.0010
248 PRODUCT COLOUR ISSUE 5 0.0010
249 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10 0.0010
250 PRODUCT DISTRIBUTION ISSUE 9 0.0010
251 AXILLARY MASS 1 0.0010
252 ABSCESS JAW 1 0.0010
253 MICROCYTIC ANAEMIA 2 0.0010
254 POST PROCEDURAL DISCOMFORT 2 0.0010
255 ATTENTION DEFICIT HYPERACTIVITY DISORDER 4 0.0009
256 BONE DEMINERALISATION 1 0.0009
257 LIP OEDEMA 4 0.0009
258 FEBRILE BONE MARROW APLASIA 4 0.0009
259 ASTERIXIS 1 0.0009
260 BLADDER DILATATION 1 0.0009
261 INJECTION SITE INFECTION 3 0.0009
262 METASTASES TO LIVER 16 0.0009
263 EMOTIONAL DISORDER 28 0.0009
264 PRODUCT LEAKAGE 5 0.0009
265 OSTEONECROSIS OF JAW 22 0.0009
266 GASTROINTESTINAL HYPOMOTILITY 2 0.0009
267 MICTURITION DISORDER 3 0.0009
268 DERMATITIS EXFOLIATIVE GENERALISED 3 0.0009
269 AORTIC STENOSIS 3 0.0009
270 MENOPAUSAL SYMPTOMS 2 0.0009
271 PERFORMANCE STATUS DECREASED 4 0.0009
272 OSTEOPENIA 13 0.0009
273 ACUTE CORONARY SYNDROME 7 0.0008
274 URINARY TRACT OBSTRUCTION 2 0.0008
275 URINARY HESITATION 2 0.0008
276 URINE FLOW DECREASED 2 0.0008
277 GASTROINTESTINAL TOXICITY 4 0.0008
278 HEPATITIS CHOLESTATIC 5 0.0008
279 HUMERUS FRACTURE 4 0.0008
280 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
281 CYTOPENIA 10 0.0008
282 CRYING 29 0.0008
283 ERYSIPELAS 4 0.0008
284 HYPOCALCAEMIA 15 0.0008
285 RETINAL ARTERY OCCLUSION 2 0.0008
286 ACNE 60 0.0008
287 ABORTION MISSED 1 0.0008
288 CEREBRAL ISCHAEMIA 4 0.0008
289 VENTRICULAR DYSFUNCTION 2 0.0008
290 ADJUSTMENT DISORDER 1 0.0008
291 HEPATITIS TOXIC 2 0.0008
292 MALIGNANT NEOPLASM PROGRESSION 78 0.0008
293 CEREBRAL ATROPHY 3 0.0008
294 HYPERPHAGIA 3 0.0008
295 BREAST PAIN 8 0.0007
296 TERMINAL STATE 5 0.0007
297 GINGIVITIS 4 0.0007
298 VITAMIN B12 DEFICIENCY 3 0.0007
299 HAEMATURIA 25 0.0007
300 CHOLESTASIS 14 0.0007
301 TENOSYNOVITIS 2 0.0007
302 HYPERCHOLESTEROLAEMIA 7 0.0007
303 GASTROINTESTINAL PERFORATION 3 0.0007
304 STREPTOCOCCAL INFECTION 4 0.0007
305 ALVEOLITIS 1 0.0007
306 HEPATIC CYTOLYSIS 9 0.0007
307 VITAMIN D DECREASED 6 0.0007
308 METASTASIS 5 0.0007
309 BLADDER TRANSITIONAL CELL CARCINOMA 1 0.0007
310 TOXIC SKIN ERUPTION 7 0.0007
311 METASTASES TO LUNG 8 0.0007
312 HYPERVENTILATION 4 0.0007
313 DRUG LEVEL DECREASED 7 0.0007
314 LUMBAR SPINAL STENOSIS 2 0.0007
315 VENTRICULAR EXTRASYSTOLES 7 0.0007
316 ISCHAEMIC STROKE 12 0.0007
317 THYROIDITIS 2 0.0007
318 CEREBROVASCULAR DISORDER 2 0.0007
319 HEPATIC FAILURE 20 0.0007
320 HEPATOCELLULAR CARCINOMA 5 0.0007
321 ACIDOSIS 5 0.0007
322 DYSPAREUNIA 3 0.0007
323 RECTAL CANCER 2 0.0007
324 APPENDICITIS 6 0.0006
325 AGGRESSION 32 0.0006
326 BREAST CANCER RECURRENT 2 0.0006
327 TESTICULAR PAIN 2 0.0006
328 SINUS BRADYCARDIA 6 0.0006
329 VULVOVAGINAL DRYNESS 2 0.0006
330 PELVIC PAIN 11 0.0006
331 BLOOD CALCIUM ABNORMAL 1 0.0006
332 BLOOD UREA INCREASED 10 0.0006
333 PRIAPISM 2 0.0006
334 EMBOLIC STROKE 2 0.0006
335 APPENDICECTOMY 2 0.0006
336 BONE LESION 2 0.0006
337 RENAL TRANSPLANT 2 0.0006
338 MUSCLE ATROPHY 7 0.0006
339 THROMBOCYTOSIS 2 0.0005
340 BRAIN NEOPLASM 5 0.0005
341 INCREASED TENDENCY TO BRUISE 5 0.0005
342 HYPOPHOSPHATAEMIA 4 0.0005
343 AURA 1 0.0005
344 NEPHROPATHY TOXIC 6 0.0005
345 PROTEIN TOTAL DECREASED 2 0.0005
346 SKIN TOXICITY 3 0.0005
347 PREMATURE LABOUR 3 0.0005
348 DISEASE RECURRENCE 25 0.0005
349 THYROID DISORDER 8 0.0005
350 SPINAL CORD COMPRESSION 2 0.0005
351 THERAPY PARTIAL RESPONDER 8 0.0005
352 VENOUS THROMBOSIS 2 0.0005
353 ANGER 17 0.0005
354 POLYNEUROPATHY 6 0.0005
355 OVARIAN CYST 5 0.0005
356 SCOLIOSIS 3 0.0005
357 HYPERTHYROIDISM 7 0.0005
358 SUICIDAL BEHAVIOUR 2 0.0005
359 BODY TEMPERATURE FLUCTUATION 1 0.0005
360 SELF-INJURIOUS IDEATION 2 0.0005
361 MUSCLE FATIGUE 2 0.0005
362 CIRCULATORY COLLAPSE 8 0.0005
363 METRORRHAGIA 8 0.0005
364 INTERVERTEBRAL DISC DISORDER 2 0.0005
365 IRRITABILITY 28 0.0005
366 DEVICE OPERATIONAL ISSUE 2 0.0005
367 WEIGHT INCREASED 104 0.0005
368 ACUTE KIDNEY INJURY 71 0.0005
369 METASTATIC NEOPLASM 2 0.0005
370 BONE CANCER 2 0.0005
371 IMMOBILE 2 0.0005
372 PARONYCHIA 2 0.0005
373 ABNORMAL BEHAVIOUR 18 0.0005
374 PRESYNCOPE 11 0.0005
375 THERAPEUTIC RESPONSE SHORTENED 15 0.0005
376 MUSCULOSKELETAL CHEST PAIN 7 0.0005
377 HEPATOTOXICITY 10 0.0004
378 MENINGIOMA 7 0.0004
379 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
380 MYOSITIS 4 0.0004
381 INTENTIONAL SELF-INJURY 9 0.0004
382 URINARY TRACT DISORDER 2 0.0004
383 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
384 DEVICE MECHANICAL ISSUE 6 0.0004
385 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 8 0.0004
386 HYPOKALAEMIA 20 0.0004
387 HYPOMAGNESAEMIA 6 0.0004
388 BONE PAIN 25 0.0004
389 PRODUCT DOSE OMISSION ISSUE 125 0.0004
390 FEAR OF INJECTION 3 0.0004
391 ENDOMETRIOSIS 2 0.0004
392 HYPOVOLAEMIC SHOCK 2 0.0004
393 LIMB OPERATION 2 0.0004
394 PERICARDITIS 7 0.0004
395 DRUG INTERACTION 66 0.0004
396 VULVOVAGINAL PAIN 2 0.0004
397 ANAEMIA 79 0.0004
398 ENTEROCOCCAL INFECTION 2 0.0004
399 RASH VESICULAR 2 0.0004
400 GUILLAIN-BARRE SYNDROME 2 0.0004
401 MAJOR DEPRESSION 3 0.0004
402 RENAL TUBULAR NECROSIS 4 0.0004
403 INFLAMMATORY MARKER INCREASED 2 0.0004
404 DYSLIPIDAEMIA 2 0.0004
405 NEUTROPENIA 53 0.0004
406 ATRIOVENTRICULAR BLOCK 3 0.0004
407 GYNAECOMASTIA 12 0.0004
408 HYPERBILIRUBINAEMIA 4 0.0004
409 FOETAL DEATH 2 0.0004
410 FOOD CRAVING 2 0.0004
411 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
412 POLYARTHRITIS 2 0.0004
413 FULL BLOOD COUNT ABNORMAL 4 0.0004
414 LOW BIRTH WEIGHT BABY 3 0.0004
415 PHARYNGOLARYNGEAL PAIN 2 0.0004
416 BLOOD POTASSIUM ABNORMAL 1 0.0004
417 COMPRESSION FRACTURE 2 0.0004
418 HIP SURGERY 2 0.0004
419 HYDROCEPHALUS 2 0.0004
420 HYPERAESTHESIA 3 0.0004
421 FAECALOMA 2 0.0004
422 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
423 SPINAL COMPRESSION FRACTURE 3 0.0004
424 ELECTROCARDIOGRAM QT PROLONGED 13 0.0004
425 EMBOLISM 3 0.0004
426 INJECTION SITE INJURY 2 0.0004
427 URINARY RETENTION 12 0.0004
428 HYPERTENSIVE CRISIS 4 0.0004
429 HUNGER 5 0.0004
430 INTRACRANIAL PRESSURE INCREASED 2 0.0004
431 INCORRECT DOSE ADMINISTERED 80 0.0004
432 PRODUCT CONTAINER ISSUE 3 0.0003
433 NEOPLASM 4 0.0003
434 PYELONEPHRITIS 3 0.0003
435 ABORTION 1 0.0003
436 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
437 HYPERTRIGLYCERIDAEMIA 2 0.0003
438 SPINAL PAIN 4 0.0003
439 INJECTION SITE PAIN 104 0.0003
440 ENERGY INCREASED 2 0.0003
441 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
442 RESPIRATORY RATE INCREASED 3 0.0003
443 PROSTATE CANCER 27 0.0003
444 THERAPEUTIC PRODUCT EFFECT DECREASED 15 0.0003
445 ANAL INCONTINENCE 3 0.0003
446 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
447 BONE MARROW DISORDER 1 0.0003
448 PALLOR 9 0.0003
449 PNEUMONITIS 9 0.0003
450 OFF LABEL USE 289 0.0003
451 TENSION 2 0.0003
452 INSURANCE ISSUE 5 0.0003
453 PNEUMONIA BACTERIAL 3 0.0003
454 DYSURIA 12 0.0003
455 UROSEPSIS 3 0.0003
456 INJECTION SITE EXTRAVASATION 4 0.0003
457 HYPERCALCAEMIA 4 0.0003
458 DRUG DIVERSION 2 0.0003
459 AGRANULOCYTOSIS 6 0.0003
460 HEPATIC ENCEPHALOPATHY 3 0.0003
461 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 15 0.0003
462 SYNCOPE 32 0.0003
463 FEBRILE NEUTROPENIA 21 0.0003
464 OSTEOPOROSIS 13 0.0003
465 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
466 LOWER LIMB FRACTURE 6 0.0003
467 SENSORY DISTURBANCE 5 0.0003
468 PRODUCT DOSE OMISSION 20 0.0003
469 POLYP 2 0.0003
470 VITREOUS FLOATERS 3 0.0003
471 THROMBOCYTOPENIA 34 0.0003
472 CARDIAC FAILURE ACUTE 2 0.0003
473 ANXIETY DISORDER 1 0.0003
474 POOR QUALITY DEVICE USED 3 0.0003
475 WRONG PRODUCT ADMINISTERED 2 0.0003
476 GINGIVAL BLEEDING 4 0.0003
477 ACUTE HEPATIC FAILURE 4 0.0003
478 BLOOD TESTOSTERONE DECREASED 2 0.0003
479 LARGE INTESTINE POLYP 2 0.0003
480 NERVOUS SYSTEM DISORDER 9 0.0003
481 AUTOIMMUNE HEPATITIS 2 0.0003
482 EXTRASYSTOLES 2 0.0003
483 PULMONARY EMBOLISM 27 0.0003
484 PULMONARY TOXICITY 2 0.0003
485 HAND FRACTURE 2 0.0003
486 HYPOTHYROIDISM 9 0.0003
487 IMPAIRED QUALITY OF LIFE 4 0.0003
488 DISTURBANCE IN ATTENTION 15 0.0003
489 ABDOMINAL PAIN LOWER 7 0.0003
490 VISUAL FIELD DEFECT 2 0.0003
491 MOUTH HAEMORRHAGE 2 0.0003
492 INJECTION SITE NODULE 3 0.0003
493 DRUG RESISTANCE 7 0.0003
494 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
495 BONE DENSITY ABNORMAL 1 0.0003
496 FISTULA 3 0.0003
497 MYOCARDIAL ISCHAEMIA 3 0.0003
498 EAR INFECTION 7 0.0003
499 MYOCARDITIS 3 0.0003
500 MENSTRUATION IRREGULAR 7 0.0003
501 BOWEL MOVEMENT IRREGULARITY 2 0.0003
502 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
503 INTERCEPTED PRODUCT ADMINISTRATION ERROR 2 0.0003
504 PULMONARY FIBROSIS 5 0.0003
505 JAUNDICE 7 0.0003
506 OEDEMA 14 0.0003
507 HYPOALBUMINAEMIA 2 0.0003
508 ACUTE MYELOID LEUKAEMIA 4 0.0003
509 TORSADE DE POINTES 2 0.0003
510 ATAXIA 3 0.0003
511 HAEMATOCRIT DECREASED 5 0.0003
512 TRICUSPID VALVE INCOMPETENCE 2 0.0003
513 MYOCLONUS 3 0.0003
514 GINGIVAL PAIN 2 0.0003
515 OBESITY 4 0.0003
516 NOCTURIA 3 0.0002
517 BLOOD POTASSIUM INCREASED 4 0.0002
518 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 44 0.0002
519 OSTEONECROSIS 8 0.0002
520 SPINAL OPERATION 3 0.0002
521 ESCHERICHIA INFECTION 2 0.0002
522 PHARYNGITIS 3 0.0002
523 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
524 HAIR COLOUR CHANGES 3 0.0002
525 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
526 ABDOMINAL PAIN 56 0.0002
527 SECOND PRIMARY MALIGNANCY 2 0.0002
528 RASH PRURITIC 13 0.0002
529 GAIT INABILITY 8 0.0002
530 ACUTE MYOCARDIAL INFARCTION 7 0.0002
531 PYREXIA 82 0.0002
532 CARDIOVASCULAR DISORDER 6 0.0002
533 COGNITIVE DISORDER 11 0.0002
534 AORTIC VALVE INCOMPETENCE 1 0.0002
535 ASTHENIA 88 0.0002
536 ALCOHOLISM 1 0.0002
537 RECTAL HAEMORRHAGE 10 0.0002
538 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
539 ARRHYTHMIA 11 0.0002
540 BLOOD MAGNESIUM DECREASED 2 0.0002
541 DEVICE LEAKAGE 10 0.0002
542 RESPIRATORY TRACT INFECTION 6 0.0002
543 ABDOMINAL DISTENSION 24 0.0002
544 MENTAL DISORDER 10 0.0002
545 BEDRIDDEN 3 0.0002
546 ORAL CANDIDIASIS 3 0.0002
547 GROIN PAIN 2 0.0002
548 GRIP STRENGTH DECREASED 2 0.0002
549 ADVERSE REACTION 3 0.0002
550 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
551 EXPOSURE DURING PREGNANCY 14 0.0002
552 HYPERHIDROSIS 29 0.0002
553 RASH MACULO-PAPULAR 5 0.0002
554 CARDIOTOXICITY 2 0.0002
555 OPTIC NEURITIS 2 0.0002
556 LEUKOPENIA 11 0.0002
557 HYPERGLYCAEMIA 8 0.0002
558 RETINAL DETACHMENT 2 0.0002
559 DEEP VEIN THROMBOSIS 14 0.0002
560 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
561 FLANK PAIN 2 0.0002
562 DEVICE OCCLUSION 3 0.0002
563 PHOTOPHOBIA 4 0.0002
564 DEPRESSED MOOD 11 0.0002
565 SEIZURE 24 0.0002
566 MYELODYSPLASTIC SYNDROME 3 0.0002
567 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
568 DYSSTASIA 6 0.0002
569 CEREBRAL INFARCTION 5 0.0002
570 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
571 URINARY INCONTINENCE 6 0.0002
572 HOSPICE CARE 2 0.0002
573 NEOPLASM PROGRESSION 7 0.0002
574 EPISTAXIS 15 0.0002
575 CARDIAC FAILURE 16 0.0002
576 CARDIAC FAILURE CONGESTIVE 16 0.0002
577 HYPOTHERMIA 2 0.0002
578 VERTIGO 12 0.0002
579 PANCYTOPENIA 11 0.0002
580 DIABETES MELLITUS 15 0.0002
581 SUICIDAL IDEATION 18 0.0002
582 MOTOR DYSFUNCTION 2 0.0002
583 NEPHROLITHIASIS 9 0.0002
584 HEPATITIS 5 0.0002
585 INITIAL INSOMNIA 2 0.0002
586 DEVICE RELATED INFECTION 3 0.0002
587 PRODUCT PREPARATION ERROR 4 0.0002
588 POOR VENOUS ACCESS 2 0.0002
589 LUNG INFECTION 3 0.0002
590 UNDERDOSE 14 0.0002
591 APLASTIC ANAEMIA 1 0.0002
592 WEIGHT FLUCTUATION 2 0.0002
593 BLOOD LACTIC ACID INCREASED 1 0.0002
594 JOINT DISLOCATION 2 0.0002
595 SUDDEN DEATH 2 0.0002
596 HYPERTENSION 40 0.0002
597 SURGERY 11 0.0002
598 PRODUCT USE IN UNAPPROVED INDICATION 46 0.0002
599 ANAL ABSCESS 1 0.0002
600 DECREASED ACTIVITY 2 0.0002
601 BIPOLAR DISORDER 2 0.0002
602 SKIN LACERATION 2 0.0002
603 MANIA 3 0.0002
604 HEADACHE 114 0.0002
605 GASTROINTESTINAL PAIN 2 0.0002
606 AUTISM SPECTRUM DISORDER 1 0.0002
607 DENTAL CARIES 2 0.0002
608 PLEURAL EFFUSION 11 0.0002
609 LIP SWELLING 6 0.0002
610 TRANSAMINASES INCREASED 4 0.0002
611 TOOTH DISORDER 4 0.0002
612 DEMENTIA 5 0.0002
613 NEUROPATHY PERIPHERAL 17 0.0002
614 ACUTE PULMONARY OEDEMA 1 0.0002
615 FACE OEDEMA 3 0.0002
616 HEMIPARESIS 3 0.0002
617 ATRIAL FIBRILLATION 17 0.0002
618 ANGINA PECTORIS 5 0.0002
619 HYPERSOMNIA 5 0.0002
620 TINNITUS 8 0.0002
621 VOMITING 81 0.0002
622 ELECTROLYTE IMBALANCE 2 0.0002
623 EYELID OEDEMA 2 0.0002
624 LIVER FUNCTION TEST ABNORMAL 5 0.0002
625 POST PROCEDURAL HAEMORRHAGE 2 0.0002
626 NEUTROPHIL COUNT DECREASED 7 0.0002
627 DEPRESSION 39 0.0002
628 EOSINOPHILIA 3 0.0002
629 SEXUAL DYSFUNCTION 2 0.0002
630 MYALGIA 29 0.0002
631 COLD SWEAT 3 0.0002
632 NASAL CONGESTION 10 0.0002
633 TACHYCARDIA 15 0.0002
634 PRODUCT PRESCRIBING ERROR 4 0.0002
635 CHOLECYSTITIS 2 0.0002
636 POLLAKIURIA 7 0.0002
637 INTERSTITIAL LUNG DISEASE 8 0.0002
638 BONE DISORDER 3 0.0002
639 EPILEPSY 5 0.0002
640 INTERCEPTED PRODUCT PREPARATION ERROR 2 0.0002
641 INJECTION SITE MASS 6 0.0002
642 LIMB DISCOMFORT 5 0.0002
643 HEPATIC STEATOSIS 3 0.0002
644 INJECTION SITE DISCOLOURATION 2 0.0002
645 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
646 BONE DENSITY DECREASED 5 0.0002
647 BLOOD URINE PRESENT 3 0.0002
648 PROTEINURIA 3 0.0002
649 POST PROCEDURAL COMPLICATION 3 0.0002
650 DEVICE ISSUE 14 0.0002
651 HAEMOGLOBIN DECREASED 16 0.0002
652 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
653 NIGHT SWEATS 5 0.0002
654 DECREASED APPETITE 36 0.0002
655 INJECTION SITE INDURATION 2 0.0002
656 DEAFNESS 4 0.0002
657 TOOTH INFECTION 2 0.0002
658 OROPHARYNGEAL PAIN 14 0.0002
659 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
660 APPETITE DISORDER 1 0.0002
661 ABDOMINAL PAIN UPPER 31 0.0002
662 HAIR TEXTURE ABNORMAL 2 0.0001
663 PAIN IN EXTREMITY 44 0.0001
664 TYPE 2 DIABETES MELLITUS 5 0.0001
665 CONFUSIONAL STATE 24 0.0001
666 TASTE DISORDER 3 0.0001
667 BLINDNESS 6 0.0001
668 BODY TEMPERATURE INCREASED 3 0.0001
669 FEELING HOT 9 0.0001
670 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
671 ABNORMAL DREAMS 4 0.0001
672 HAEMOPTYSIS 4 0.0001
673 DERMATITIS 3 0.0001
674 COVID-19 25 0.0001
675 BACK PAIN 33 0.0001
676 SKIN REACTION 2 0.0001
677 BLINDNESS UNILATERAL 2 0.0001
678 LYMPHOPENIA 2 0.0001
679 LYMPHADENOPATHY 5 0.0001
680 HEPATOCELLULAR INJURY 2 0.0001
681 ANXIETY 40 0.0001
682 LIVER FUNCTION TEST INCREASED 3 0.0001
683 SWELLING FACE 9 0.0001
684 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
685 HYPOKINESIA 2 0.0001
686 C-REACTIVE PROTEIN INCREASED 5 0.0001
687 APATHY 2 0.0001
688 GASTROENTERITIS 2 0.0001
689 AGITATION 10 0.0001
690 BLINDNESS TRANSIENT 1 0.0001
691 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
692 PSYCHOTIC DISORDER 4 0.0001
693 CARDIOMYOPATHY 2 0.0001
694 CHEST PAIN 25 0.0001
695 PULMONARY MASS 2 0.0001
696 HAEMORRHAGE INTRACRANIAL 2 0.0001
697 RESPIRATORY DISORDER 4 0.0001
698 PREMATURE BABY 4 0.0001
699 PRODUCT AVAILABILITY ISSUE 3 0.0001
700 INJECTION SITE RASH 4 0.0001
701 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
702 APHTHOUS ULCER 1 0.0001
703 BREAST CANCER 12 0.0001
704 EJECTION FRACTION DECREASED 2 0.0001
705 BASAL CELL CARCINOMA 2 0.0001
706 PALPITATIONS 15 0.0001
707 DRUG-INDUCED LIVER INJURY 4 0.0001
708 ALOPECIA 25 0.0001
709 AFFECTIVE DISORDER 1 0.0001
710 CYANOSIS 2 0.0001
711 DIZZINESS 63 0.0001
712 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
713 BLOOD ALBUMIN DECREASED 1 0.0001
714 HALLUCINATION, AUDITORY 2 0.0001
715 RASH ERYTHEMATOUS 6 0.0001
716 LOSS OF CONSCIOUSNESS 16 0.0001
717 BLOOD DISORDER 1 0.0001
718 HYPERSENSITIVITY 23 0.0001
719 INSOMNIA 33 0.0001
720 MUSCLE TIGHTNESS 2 0.0001
721 NEURALGIA 3 0.0001
722 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 25 0.0001
723 URINARY TRACT INFECTION 21 0.0001
724 OEDEMA PERIPHERAL 15 0.0001
725 ASPHYXIA 1 0.0001
726 PLATELET COUNT DECREASED 13 0.0001
727 CONDITION AGGRAVATED 37 0.0001
728 LETHARGY 7 0.0001
729 SKIN DISORDER 4 0.0001
730 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
731 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
732 CANDIDA INFECTION 2 0.0001
733 FLUSHING 12 0.0001
734 FLUID RETENTION 6 0.0001
735 ANAPHYLACTIC SHOCK 3 0.0001
736 ANURIA 1 0.0001
737 DEVICE DEFECTIVE 2 0.0001
738 SEPTIC SHOCK 5 0.0001
739 ECZEMA 6 0.0001
740 CONSTIPATION 25 0.0001
741 MUCOSAL INFLAMMATION 3 0.0001
742 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
743 MUSCULAR WEAKNESS 13 0.0001
744 JOINT STIFFNESS 3 0.0001
745 DEVICE USE ISSUE 2 0.0001
746 PRODUCT STORAGE ERROR 10 0.0001
747 AMENORRHOEA 2 0.0001
748 GASTRITIS 3 0.0001
749 DIARRHOEA 73 0.0001
750 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
751 DYSPNOEA 64 0.0001
752 GENERAL PHYSICAL HEALTH DETERIORATION 13 0.0001
753 THIRST 2 0.0001
754 CEREBRAL HAEMORRHAGE 4 0.0001
755 GOUT 2 0.0001
756 MYELOSUPPRESSION 4 0.0001
757 GASTROENTERITIS VIRAL 2 0.0001
758 HOSPITALISATION 17 0.0001
759 OSTEOMYELITIS 2 0.0001
760 RESPIRATORY FAILURE 8 0.0001
761 DEVICE DELIVERY SYSTEM ISSUE 3 0.0001
762 FATIGUE 85 0.0001
763 ADVERSE EVENT 10 0.0001
764 RHINORRHOEA 7 0.0001
765 ARTHRALGIA 45 0.0001
766 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
767 FEELING COLD 3 0.0001
768 INFLUENZA 12 0.0001
769 BLOOD CHOLESTEROL INCREASED 5 0.0001
770 INTESTINAL OBSTRUCTION 4 0.0001
771 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
772 FRACTURE 2 0.0001
773 FOOT FRACTURE 2 0.0001
774 SLEEP APNOEA SYNDROME 2 0.0001
775 ACUTE RESPIRATORY FAILURE 2 0.0001
776 ATELECTASIS 1 0.0001
777 NASOPHARYNGITIS 19 0.0001
778 CHOKING 2 0.0001
779 CHILLS 12 0.0001
780 LABORATORY TEST ABNORMAL 3 0.0001
781 RENAL INJURY 3 0.0001
782 MATERNAL EXPOSURE DURING PREGNANCY 9 0.0001
783 BLADDER DISORDER 1 0.0001
784 UPPER LIMB FRACTURE 2 0.0001
785 COUGH 28 0.0001
786 APHASIA 3 0.0001
787 SUICIDE ATTEMPT 6 0.0001
788 FOETAL EXPOSURE DURING PREGNANCY 8 0.0001
789 DRUG ADMINISTRATION ERROR 3 0.0001
790 THERAPY CESSATION 5 0.0001
791 RIB FRACTURE 2 0.0001
792 ILLNESS 10 0.0001
793 WEIGHT DECREASED 27 0.0001
794 CARDIO-RESPIRATORY ARREST 4 0.0001
795 HAEMORRHAGE 10 0.0001
796 URTICARIA 16 0.0001
797 HEAD INJURY 3 0.0001
798 HALLUCINATION, VISUAL 2 0.0001
799 GAIT DISTURBANCE 18 0.0001
800 METABOLIC ACIDOSIS 3 0.0001
801 MOVEMENT DISORDER 3 0.0001
802 HIP FRACTURE 3 0.0001
803 IRRITABLE BOWEL SYNDROME 2 0.0001
804 HYPOACUSIS 4 0.0001
805 POOR QUALITY SLEEP 2 0.0001
806 HALLUCINATION 7 0.0001
807 UNEVALUABLE EVENT 7 0.0001
808 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
809 PRODUCT DISPENSING ERROR 2 0.0001
810 MYOCARDIAL INFARCTION 16 0.0001
811 INJECTION SITE SWELLING 7 0.0001
812 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
813 ASPIRATION 1 0.0001
814 NAUSEA 72 0.0001
815 MELAENA 2 0.0001
816 ANGIOEDEMA 4 0.0001
817 VIRAL INFECTION 3 0.0001
818 MEDICATION ERROR 5 0.0001
819 SEPSIS 10 0.0001
820 DRUG INEFFECTIVE 118 0.0001
821 COLITIS ULCERATIVE 4 0.0001
822 DRUG DOSE OMISSION BY DEVICE 7 0.0001
823 ORAL PAIN 2 0.0001
824 PANCREATITIS ACUTE 2 0.0001
825 BLOOD CALCIUM DECREASED 1 0.0001
826 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
827 MUSCLE SPASMS 16 0.0001
828 SKIN DISCOLOURATION 4 0.0001
829 SHOCK 2 0.0001
830 MUSCLE TWITCHING 2 0.0001
831 NIGHTMARE 3 0.0001
832 DRY MOUTH 7 0.0001
833 HYPOXIA 3 0.0001
834 PRODUCT USE ISSUE 16 0.0001
835 RASH 37 0.0001
836 BLOOD IRON DECREASED 1 0.0001
837 THERAPY INTERRUPTED 6 0.0001
838 ACCIDENT 1 0.0001
839 LOCALISED INFECTION 2 0.0001
840 CEREBROVASCULAR ACCIDENT 14 0.0001
841 PARAESTHESIA 13 0.0001
842 MENTAL IMPAIRMENT 2 0.0001
843 STOMATITIS 5 0.0001
844 DRY SKIN 11 0.0001
845 ADRENAL INSUFFICIENCY 1 0.0001
846 PANIC ATTACK 3 0.0001
847 ILL-DEFINED DISORDER 5 0.0001
848 RESTLESSNESS 3 0.0001
849 LIVER INJURY 2 0.0001
850 ABNORMAL WEIGHT GAIN 1 0.0001
851 HEPATIC FUNCTION ABNORMAL 3 0.0001
852 HYPOAESTHESIA 12 0.0001
853 VISION BLURRED 11 0.0001
854 PNEUMONIA ASPIRATION 2 0.0001
855 COLITIS 3 0.0001
856 PRODUCT COMPLAINT 2 0.0001
857 BLOOD PRESSURE INCREASED 12 0.0001
858 INFLAMMATION 4 0.0001
859 PNEUMONIA 25 0.0001
860 HAEMATOMA 2 0.0001
861 DIPLOPIA 2 0.0001
862 AMNESIA 5 0.0001
863 SPEECH DISORDER 4 0.0001
864 INJECTION SITE HAEMORRHAGE 6 0.0001
865 THROMBOSIS 6 0.0001
866 FEAR 2 0.0001
867 BLOOD BILIRUBIN INCREASED 2 0.0001
868 DEATH 63 0.0001
869 MEMORY IMPAIRMENT 10 0.0001
870 INJECTION SITE REACTION 5 0.0001
871 DIVERTICULITIS 2 0.0001
872 PAIN 44 0.0001
873 OXYGEN SATURATION DECREASED 4 0.0001
874 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
875 HYPONATRAEMIA 4 0.0001
876 INTENTIONAL DOSE OMISSION 2 0.0001
877 ACCIDENTAL UNDERDOSE 1 0.0001
878 FALL 23 0.0001
879 ANOSMIA 1 0.0001
880 MUSCULOSKELETAL STIFFNESS 6 0.0001
881 MALAISE 30 0.0001
882 GASTROINTESTINAL DISORDER 6 0.0001
883 FEELING ABNORMAL 16 0.0001
884 BONE LOSS 1 0.0001
885 LACRIMATION INCREASED 2 0.0001
886 CORONARY ARTERY DISEASE 2 0.0001
887 PERIPHERAL SWELLING 10 0.0001
888 ANKLE FRACTURE 1 0.0001
889 FEMUR FRACTURE 2 0.0001
890 WHITE BLOOD CELL COUNT DECREASED 7 0.0001
891 SOMNOLENCE 13 0.0001
892 VISUAL IMPAIRMENT 8 0.0001
893 CARDIAC DISORDER 6 0.0001
894 CYSTITIS 2 0.0001
895 INJECTION SITE BRUISING 5 0.0001
896 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
897 LUNG DISORDER 3 0.0001
898 CHOLELITHIASIS 2 0.0001
899 INFLUENZA LIKE ILLNESS 5 0.0001
900 STAPHYLOCOCCAL INFECTION 2 0.0001
901 HEART RATE INCREASED 6 0.0001
902 DRY EYE 3 0.0001
903 DEHYDRATION 8 0.0001
904 NEOPLASM MALIGNANT 4 0.0001
905 HYPOTENSION 12 0.0001
906 CELLULITIS 3 0.0001
907 RENAL IMPAIRMENT 5 0.0001
908 TOXICITY TO VARIOUS AGENTS 10 0.0001
909 DEVICE USE ERROR 2 0.0001
910 NERVOUSNESS 3 0.0001
911 PRURITUS 22 0.0001
912 RASH MACULAR 2 0.0001
913 HEART RATE DECREASED 2 0.0001
914 PANCREATITIS 3 0.0001
915 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
916 BRADYCARDIA 3 0.0001
917 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
918 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
919 INFECTION 8 0.0001
920 HAEMATOCHEZIA 3 0.0001
921 TREMOR 9 0.0001
922 BLOOD GLUCOSE ABNORMAL 1 0.0001
923 DYSGEUSIA 4 0.0001
924 NECK PAIN 3 0.0001
925 BACTERIAL INFECTION 1 0.0001
926 ASTHMA 6 0.0001
927 RENAL FAILURE 7 0.0001
928 MIGRAINE 5 0.0001
929 DRUG INTOLERANCE 5 0.0001
930 DYSPHONIA 3 0.0001
931 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
932 OVERDOSE 11 0.0001
933 BLADDER CANCER 3 0.0001
934 DISORIENTATION 2 0.0001
935 THERAPEUTIC RESPONSE DECREASED 3 0.0000
936 EXTRA DOSE ADMINISTERED 2 0.0000
937 DEVICE BREAKAGE 2 0.0000
938 BONE MARROW FAILURE 1 0.0000
939 DISCOMFORT 3 0.0000
940 SINUSITIS 5 0.0000
941 CARDIAC ARREST 4 0.0000
942 TREATMENT FAILURE 4 0.0000
943 OSTEOARTHRITIS 2 0.0000
944 RENAL FAILURE ACUTE 2 0.0000
945 BALANCE DISORDER 4 0.0000
946 BLOOD PRESSURE DECREASED 3 0.0000
947 LIVER DISORDER 2 0.0000
948 INJECTION SITE PRURITUS 3 0.0000
949 THROAT IRRITATION 2 0.0000
950 HEPATIC ENZYME INCREASED 3 0.0000
951 ERYTHEMA 9 0.0000
952 SLEEP DISORDER 3 0.0000
953 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
954 DYSPHAGIA 4 0.0000
955 COMA 2 0.0000
956 MOBILITY DECREASED 3 0.0000
957 ABDOMINAL DISCOMFORT 7 0.0000
958 BLOOD PRESSURE FLUCTUATION 1 0.0000
959 BLOOD GLUCOSE DECREASED 2 0.0000
960 JOINT SWELLING 5 0.0000
961 EMOTIONAL DISTRESS 5 0.0000
962 HYPOGLYCAEMIA 2 0.0000
963 DYSPEPSIA 4 0.0000
964 ABASIA 1 0.0000
965 INJECTION SITE ERYTHEMA 5 0.0000
966 AGEUSIA 1 0.0000
967 CHEST DISCOMFORT 4 0.0000
968 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
969 MUSCULOSKELETAL PAIN 2 0.0000
970 APPLICATION SITE ERYTHEMA 1 0.0000
971 BLOOD GLUCOSE INCREASED 7 0.0000
972 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
973 ANAPHYLACTIC REACTION 2 0.0000
974 DRUG ABUSE 3 0.0000
975 FLATULENCE 2 0.0000
976 CATARACT 2 0.0000
977 ADVERSE DRUG REACTION 3 0.0000
978 BLOOD CREATININE INCREASED 2 0.0000
979 PRODUCT QUALITY ISSUE 4 0.0000
980 BURNING SENSATION 2 0.0000
981 ACCIDENTAL OVERDOSE 1 0.0000
982 BRONCHITIS 2 0.0000
983 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
984 PSORIASIS 3 0.0000
985 CONTUSION 2 0.0000
986 ARTHROPATHY 1 0.0000
987 ARTHRITIS 1 0.0000
988 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000